Koli
Non-surgical treatment for gallstone disease
Palo Alto, United States · Founded 2023
- Headquarters
- Palo Alto, California
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
About
Kōli is a medical device company developing a non-surgical alternative to treat gallstone disease through a minimally invasive implantable filter deployed in the gallbladder. The device is designed to prevent complications from gallstones obstructing the gallbladder outlet, replacing cholecystectomy for high-risk patients including the elderly and those with recent cardiac events. The company completed a first-in-human feasibility study in the Philippines and received NIH SBIR Phase II funding.
Summary
Koli is a Biotech company based in Palo Alto, United States, founded in 2023.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/koli"><img src="https://indexed.vc/api/badge/company/koli" alt="Koli on Indexed.vc" width="260" height="76" /></a>